Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C

被引:164
作者
Targher, Giovanni
Bertolini, Lorenzo
Padovani, Roberto
Rodella, Stefano
Arcaro, Guido
Day, Christopher
机构
[1] Osped Sacro Cuore don Calabria, Div Internal Med, I-37024 Negrar, VR, Italy
[2] Univ Hosp Verona, Dept Biomed & Surg Sci, Sect Endocrinol & Metab Dis, Verona, Italy
[3] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
non-alcoholic fatty liver disease; chronic viral hepatitis; atherosclerosis; metabolic syndrome; insulin resistance;
D O I
10.1016/j.jhep.2007.01.021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: To compare carotid intima-media thickness (IMT) - an index of early atherosclerosis - among patients with non-alcoholic steatohepatitis (NASH), patients with chronic hepatitis B (HBV) or C (HCV) and control subjects. Methods: We studied 60 consecutive patients with biopsy-proven NASH, 60 patients with HCV, 35 patients with HBV, and 60 healthy controls who were comparable for age and sex. Common carotid IMT was measured with ultrasonography in all participants by a single operator blinded to subjects' characteristics. Results: Carotid IMT measurements were markedly different among the groups; the lowest values were in controls, intermediate in patients with HBV or HCV, and highest in those with NASH (0.84 +/- 0.1 vs. 0.97 +/- 0.1 vs. 1.09 +/- 0.2 vs. 1.23 +/- 0.2 mm, respectively; p < 0.001). The marked differences in carotid IMT that were observed among the groups were little affected by adjustment for age, sex, body mass index, smoking, LDL cholesterol, insulin resistance (by homeostasis model assessment) and components of the Adult Treatment Panel Ill-defined metabolic syndrome. Concordantly, in logistic regression analysis, NASH, HBV and HCV predicted carotid IMT independent of potential confounders. Conclusions: These data suggest that NASH, HCV and HBV are strongly associated with early atherosclerosis independent of classical risk factors, insulin resistance and metabolic syndrome components. (C) 2007 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1126 / 1132
页数:7
相关论文
共 52 条
[1]   Recent concepts in non-alcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P .
DIABETIC MEDICINE, 2005, 22 (09) :1129-1133
[2]   No association between hepatitis C virus seropositivity and acute myocardial infarction [J].
Arcari, Christine M. ;
Nelson, Kenrad E. ;
Netski, Dale M. ;
Nieto, F. Javier ;
Gaydos, Charlotte A. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) :E53-E56
[3]  
Bilora F, 2002, GASTROEN CLIN BIOL, V26, P1001
[4]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[5]   Nonalcoholic fatty liver disease is associated with carotid atherosclerosis -: A case-control study [J].
Brea, A ;
Mosquera, D ;
Martín, E ;
Arizti, A ;
Cordero, JL ;
Ros, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1045-1050
[6]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Non-alcoholic fatty liver disease: current concepts and management strategies [J].
Day, CP .
CLINICAL MEDICINE, 2006, 6 (01) :19-25
[9]   From fat to inflammation [J].
Day, CP .
GASTROENTEROLOGY, 2006, 130 (01) :207-210
[10]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873